1. Sajadi Tabassi S. A., Martin G.P., Marriott C. (2001) THE EFFECTS OF POLYSORBATE SURFACTANTS ON THE STRUCTURE OF MUCUS GLYCOPROTEINS. DARU, 9 (1&2), 6-11.
2. Sajadi Tabassi S.A., Razavi N. (2003) Preparation and characterization of albumin microspheres encapsulated with propranolol HCl. DARU, 11(4), 137-141.
3. Tafaghodi, M., Sajadi Tabassi, S.A., Jaafari, M.R. (2004) Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Int. J. Pharm., 280, 125-135.
4. M. Tafaghodi,M. R. Jaafari,S. A. Sajadi, J. Samuel, M. Diwan (2004) Utilization of particulate and immunomudulating adjuvants for enhancement of immune response against tumors’ antigenic markers. Ir. J. Basic Med. Sci., 6(4), 278-285.
5. Sajadi Tabassi S.A., Hosseinzadeh H., Ramezani M., Moghimipour E., Mohajeri S.A. (2006) Isolation, characterization and study of enhancing effects on nasal absorption of insulin in rat of the total saponin from Acanthophyllum squarrosum. Current Drug Delivery, 3 (4), 399-404
6. Moghimipour E., Jalali A., Sajadi Tabassi S.A., Loebenberg R. (2004) The enhancing effect of sodium glycocholate and sodium salicylate on rat’s gastrointestinal permeability to insulin. Iranian J. Pharm. Res., 3(2), 87-91.
7. M. TAFAGHODI, S. A. SAJADI TABASI, M. R. JAAFARI (2006) Formulation, characterization and release studies of alginate microspheres encapsulated with tetanus toxoid. J. Biomater. Sci. Polymer Edn., 17 ( 8), 909–924.
8. Malaekeh-NikouEI B., Sajadi tabassi S.A., Jaafari M.R. (2006) The effect of different grades of PLGA on characteristics of microspheres encapsulated with Cyclosporine A. Current Drug Delivery, 3 (4), 343-349.
9. Tafaghodi, M., Sajadi Tabassi, S.A., Jaafari, M.R. (2006) Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. International Journal of Pharmaceutics 319, 37–43.
10. Jaafari, M.R., Tafaghodi, M., Sajadi Tabassi, S.A., (2005) Evaluation of the clearance characteristics of liposomes in the human nose by gamma-scintigraphy. Iranian J. Pharm. Res., 4(1), 3-11.
11. Bizhan Malaekeh-Nikouei, Sayyed A. Sajadi Tabassi, Mahmoud R. Jaafari, Nigel M. Davies (2006) The effect of complexation on characteristics and drug release from PLGA microspheres loaded by cyclosporine-cyclodextrin complex. Journal of Drug Delivery Science and Technology, 16(5), 345-350.
12. Mohsen Tafaghodi, Mahmood-Reza Jaafari, Sayyed Abolghasem Sajadi Tabassi(2006) Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN. European Journal of Pharmaceutics and Biopharmaceutics 64, 138–145.
13. Mohsen Tafaghodi, Sayyed Abolghasem Sajadi Tabassi, Mahmood-Reza Jaafari (2007) Nasal immunization study by PLGA nanospheres encapsulated with tetanus toxoid and CpG-ODN. Iranian J. Pharm. Res. 6 (3), 151-158
14. Mohsen Tafaghodi, Sayyed A Sajadi Tabassi, Nafiseh Amiri (2008) PLGA Nanospheres loaded with Autoclaved Leishmania Major (ALM) and CPG-ODN: Preparation and in-vitro Characterization. Iranian J Basic Med. Sci., 11(2), 112-119.
15. Mohsen Tafaghodi, Mahmood-Reza Jaafari, Sayyed Abolghasem Sajadi Tabassi (2008) Nasal Immunization Studies by Cationic, Fusogenic and Cationic-fusogenic Liposomes Encapsulated With Tetanus Toxoid. Current Drug Del., 5, 108-113
16. Malaekeh-Nikouei B., Sajadi S. A., Jaafari M. R. (2008), Preparation, characterization and mucoadhesive properties of chitosan coated microspheres encapsulated with cyclosporine A, Drug Development and Industrial Pharmacy, 34, 5, 492-498.
17. S. Abolghasem Sajadi Tabassi, Mohsen Tafaghodi, Mahmoud Reza Jaafari (2008) Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran microspheres, International Journal of Pharmaceutics, 360, 12-17.
18. Bizhan Malaekeh-Nikouei , Mahmoud R. Jaafari, Sayyed A. Sajadi Tabassi , Afshin Samiei (2008) The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes. Colloids and Surfaces B: Biointerfaces, 67, 238-244.
19. N. Khadem, S. A. Sajadi Tabassi, N. Ghomian, F. Eftekharzadeh (2008) Comparison of Boric Acid with Clotrimazole in the Treatment of Recurrent or Resistant Vulvovaginitis Caused by Non-Albicans Species of Candida. Iranian Journal of Medical Sciences (IJMS), Vol 33, No 4, 226-230.
20. P. Ebrahimnejad, S. A. Sajadi Tabassi, M. R. Jaafari, F. Atyabi, F. Ramezani Ghara, R. Dinarvand (2009) Preparation and characterization of poly lactide-co-glycolyde nanoparticles of SN-38. PDA Journal of Pharmaceutical Science and Technology, vol. 63 no. 6, 512-520.
21. Bizhan Malaekeh-Nikouei, Sayyed A. Sajadi Tabassi, Hossein Ashari, Ali Gholamzadeh (2009) Evaluation the effect of cyclodextrin complexation on aqueous solubility of fluorometholone to achieve ophthalmic solution. J Incl Phenom Macrocycl Chem, 65, 335-340.
22. P. Ebrahimnejad, R. Dinarvand, S. A. Sajadi Tabassi, M. R. Jaafari, F. Atyabi (2009) Development and validation of an ion-pair HPLC chromatography for simultaneous determination of lactone and carboxylate forms of SN-38 in nanoparticles. Journal of food and drug analysis, 17 (4), 246-56.
23. PedramEbrahimnejad, RassoulDinarvandad, Abolghasem Sajadi, Mahmoud RezaJaafari, Ali RezaNomani, EbrahimAzizi, MazdaRad-Malekshahi, FatemehAtyabia (2010) Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT29 cell lines. Journal of Nanomedicine, Nanotechnology, Biology and Medicine, Volume 6, Issue 3, June 2010, 478-485
24. Pedram Ebrahimnejad, Rassoul Dinarvand, Mahmoud Reza Jaafari, Seyed Abolghasem Sajadi Tabasi, Fatemeh Atyabi (2010) Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38. International Journal of Pharmaceutics, Volume 406, Issues 1-2, 15 March 2011, 122-127.
25. Sajadi Tabassi S. A., Mamaghani Sani D. (2001) Investigation of the effects of ionic surfactants on biological membranes using human erythrocytes as a model. Ir. J. Basic Med. Sci. 4, 2, 89-94.
26. Sajadi Tabassi S. A., Shafiee Nik R., Rajabi O., Abbaspour M. R., (2002) A new oral solid dosage form of insulin: releaSe and stabIlity studies. Ir. J. Basic Med. Sci., 5 (2), 75-81.
27. Moghimipour E., Sajadi Tabassi S.A., Ramazani M., Loebenberg R. (2002) Enhanced permeability of gentamicin sulfate through snake skin and liposomal membranes by different enhancers. Ir. J. Basic Med. Sci., 6 (1), 9-19.
28. Tafaghodi M., Sajadi Tabassi S.A., Jaafari M.R. (2002) Formulation, characteriazation and release studies of alginate microsphere encapsulated with tetanus toxoid for nasal immunization. Ir. J. Basic Med. Sci., 6(1), 20-31.
29. Sajadi Tabassi S.A., Jaafari M.R., Tafaghodi M., Diwan M., Samuel J. (2003) Enhancement of immune responses following co-administration of CpG oligodeoxynucleotide (CpG-ODN) and tetanus toxoid in PLGA microspheres. Ir. J. Basic Med. Sci., 6 (3), 221-236.
30. Sajadi Tabassi, S.A., Naniroudi, M.A. (2004) Investigation of the effects of polysorbate non-ionic surfactants on biological membranes using human erythrocytes as a model. Ir. J. Basic Med. Sci., 7(3), 157-162.
31. Sajadi Tabassi, S. A., Tafaghodi, M., Jaafari, M. R. (2004) Dextran microspheres containing tetanus toxoid as a potential delivery system for nasal immunization: in vitro and in vivo characterization. Ir. J. Basic Med. Sci., 7(2), 88-98.
32. Malaekeh, B., Sajadi Tabassi S.A., Jaafari M.R. (2004) Preparation of biodegradable microspheres encapsulated with Cyclosporine A and evaluation of some factors affecting encapsulation efficiency. Ir. J. Basic Med. Sci., 7(4), 240-249.
33. Zahra Ghiassi, S. Abolghasem Sajadi Tabassi, Mohsen Tafaghodi (2007) Preparation and characterization of alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Iranian J. Basic Med. Sci., 10 (2), 90-98.
ب) انتشار مقاله در ژورنالهاي علمي پژوهشي سطح Index Medicus, Pubmed, Medline) : II )
1- Bizhan Malaekeh-Nikouei, Sayyed A. Sajadi Tabassi, Mahmoud R. Jaafari (2007) Preparation, characterization and mucoadhesive evaluation of chitosan coated liposomes containing cyclosporine A. Saudi Pharmaceutical Journal, 15 (3-4), 176-182.
2- Mohsen Tafaghodi, S. Abolghasem Sajadi Tabassi, Maria Kharazizadeh (2008) Preparation and characterization of PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and Quillaja saponin. Saudi Pharmaceutical Journal, 16 (1), 43-49.
3- Sajadi Tabassi S.A., Hosseinzadeh H., Mohajeri S.A. (2003) Absorption enhancing effects of Acanthophyllum total saponin on intranasal insulin in rat. Iranian Journal of Diabetes and Lipid Disorders, vol 2, No 1, 17-24.
4- Malaekeh-Nikouei, B., Jaafari M.R., Sajadi Tabassi S.A., Samiee A. (2005) Preparation of fusogenic liposomes encapsulated with cyclosporine A and evaluation of its immunosuppressive effects on human T-cells. Pharmaceutical Sciences (Tabriz), Summer 2005, 1-9.
ج) انتشار مقاله در ژورنالهاي علمي پژوهشي سطح Scopus, Chemical Abstract, Embase, Biological Abstract) : III )
1. Bizhan Malaekeh-Nikouei, Sayyed A. Sajadi Tabassi, Mahmoud R. Jaafari, Nigel M. Davies (2006) Preparation and characterization of PLGA microspheres loaded with cyclosporine-cyclodextrin complex., Iranian Journal of Pharmaceutical Sciences, 1(4): 191-198.
2. Tafaghodi M., Sajadi Tabassi S.A., Payan M. (2008) Alginate microspheres as a delivery system and adjuvant for autoclaved Leishmania major (ALM) and Quillaja saponin (QS) - Preparation and characterization”, Iranian J. Pharm. Sci., 3(2), 61-68.
د) انتشار مقاله در ژورنالهاي علمي پژوهشي سطح IV: (ساير سايتهاي تخصصي)
1. Tafaghodi M., Sajadi Tabassi S.A., Jaafari M.R. (2002) Nasal drug delivery: characteristics and limitations. Razi Pharmaceutical Journal, 11, 32-42.
2. Tafaghodi M., Sajadi Tabassi S.A., Jaafari M.R. (2004) Mucosal immunization. Razi Pharmaceutical Journal, 175, 17-24.
3. Tafaghodi M., Sajadi Tabassi S.A., Jaafari M.R. (2004) Vaccine Adjuvants. Razi Pharmaceutical Journal. 174, 34-45.
و) ارائه مقاله دركنگره ها يا سمينارهاي خارجي:
1- Sajadi Tabassi S.A., Ramazani M., Moghimipour E. (2001) Determination of physico-chemical properties and membrane disrupting effects of the total saponin derived from Acanthophyllum squarrosum root. Proc. British Pharmaceutical Conference, Glasgow, UK, p 178
2- Sajadi Tabassi S.A., Razavi N. (2002) Preparation and characterization of albumin microspheres encapsulated with propranolol HCl. J. Pharm. Pharmacol., 54, S93, Manchester, UK
3- Ramezani M., Moghimipour E., Sajadi Tabassi S.A., Loebenberg R. (2002) Enhanced permeability of snake skin model using total saponins of Acanthophyllum squarrosum. Proc. World Congress of Pharmacy, FIP 2002, Nice France
4- Sajadi Tabassi, S.A., Hosseinzadeh, H., Mohajeri, S.A. (2003) Investigation of absorption enhancing effect of Acanthophyllum total saponin on intranasal delivery of insulin and blood glucose levels in rat. J. Pharm. Pharmacol. 55 (supplement), S42 (British Pharmaceutical Conference, Manchester, UK)
5- Sajadi Tabassi, S.A., Tafaghodi, M., Jaafari, M. R. (2004) Dextran microspheres as a potential delivery system for nasal immunization – in vitro and in vivo characterization. Proc. Intl. Meeting on Pharm., Biopharm. Pharm. Tech., Nürenberg Messe, Nuremberg, Germany
6- Sajadi Tabassi, S.A., Tafaghodi, M., Jaafari, M.R., Zakavi, S.R., Momennejad, M. (2004) Gamma-scintigraphic evaluation of the clearance characteristics of microspheres in human nose. Proc. 3rd Pharm. Sci. World Cong., Kyoto, Japan
7- Sajadi Tabassi, S.A., Malaekeh-Nikouei, B., Jaafari, M.R. (2005) Preparation and characterization of biodegradable microspheres encapsulated with Cyclosporine A using different grades of PLGA. 1st PharmSciFair, Nice, France, P O 238
8- Sajadi Tabassi, S.A.; Mashhadi, T.; Ramazani, M. (2006) Isolation and investigation of surface activity, membrane toxicity and absorption enhancing effects of the total saponins from Acanthophyllum korshinskyi. Proc.The Tenth International Symposium on Oncolog Pharmacy Practice (ISOPP-X), Kuala Lumpur, Malaysia, Journal of Oncology Pharmacy Practice, 12 (1), Poster 5.
9- Sajadi Tabassi, S.A., Malaekeh-Nikouei, B., Jaafari, M.R., Davies N. (2006) The effect of complexation on characteristics of and drug release from PLGA microspheres loaded by cyclosporine-cyclodextrin complex. The 33 rd Annual Meeting of the Controlled Release Society, Vienna, Austria. (Poster)
10- S. A. Sajadi Tabassi, M. Tafaghodi, M. R. Jaafari (2007) Nasal Immunization Studies by Cationic, Fusogenic and Cationic-fusogenic Liposomes Encapsulated with Tetanus Toxoid. The 9th Commonwealth Pharmaceutical Association Conference, Kuala Lumpur, Malaysia, (poster).
11- S. A. Sajadi Tabassi, A. Eliaspour; STUDY OF TRANSDERMAL DELIVERY OF AMITRIPTYLINE AND THE EFFECT OF SOME PENETRATION ENHANCERS., 22nd Federation of Asian Pharmaceutical Associations (FAPA) Congress, Nov 2008, Singapore, P-70
12- Sayyed A. Sajadi Tabassi, Mohsen Tafaghodi, Nafiseh Amiri; PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN- Preparation and in vitro characterization. VACCINE 3RD GLOBAL CONGRESS, 4-6 Oct 2009, Singapore, Poster 1.43.
13- Eskandar Moghimipour, Seyyed Abolghassem Sajjadi Tabassi , Hadi Varghaei (2010) COMBINATION STRATEGIES FOR ENHANCING TRANSDERMAL ABSORPTION OF THEOPHYLLINE THROUGH SHED SNAKE SKIN. 22nd Federation of Asian Pharmaceutical Associations (FAPA) Congress, Nov 2008, Singapore.
14- Sayyed A. Sajadi TABASSI, P. EBRAHIMNEJAD, M.R. JAAFARI, F. ATYABI, R. DINARVAND (2010) Preparation and characterization of SN-38 nanoparticles using PLGA–PEG–Folate conjugates for folate-receptor-targeted anti-cancer therapy. International Conference on Cellular and Molecular Bioengineering, 2-4 Aug 2010, Singapore, Oral presentation.
ز) ارائه مقاله دركنگره ها يا سمينارهاي داخلي:
15- Sajadi Tabassi S.A., Moghimipour E., Ramezani M. (2000) Study of physico-chemical properties and hemolytic effects of the total saponin of Acanthophyllum squarrosum. Proc. The 1st Int. Cong. Trad. Med. Mat. Medica, Nov 2000, Tehran, I.R. Iran
16- Sajadi Tabassi S.A., Moghimipour E., Ramezani M. (2000) Isolation and determination of surface activity of the total saponin of Acanthophyllum squarrosum. Proc. 7th Iranian Seminar of Pharmaceutical Sciences. Sep 2000, Mashhad, I.R. Iran
17- Sajadi Tabassi S.A. (2001) Isolation, purification and rheological characterization of mucus glycoproteins. Proc. The 1st Seminar on Pharmaceutical Methodology, Sep 2001, Mashhad, I.R. Iran
18- Tafaghodi M., Jaafari M.R., Sajadi Tabassi S.A. (2000) Formulation and characterization of liposomes encapsulates with tetanus toxoid. Proc. 7th Iranian Seminar of Pharmaceutical Sciences. Sep 2000, Mashhad, I.R. Iran
19- Sajadi Tabassi S.A., Abedi H. (2001) Study of the hemolytic effects of antihistamines. Proc. The 1st Seminar on Pharmaceutical Methodology, Mashhad, I.R. Iran
20- Sajadi Tabassi S.A., Khalessi B., Ayatollahi S. (2001) Drug induced hemolysis: Phenothiazines and tricyclic antidepressants. Proc. 15th I. Phys. Pharmacol. Cong., Shiraz, I.R. Iran, p517
21- Moghimipour E., Sajadi Tabassi S.A., Ramezani M., Loebenberg R. (2002) The enhancement effect of Acanthophyllum squqrrosum total saponin on nasal absorption of gentamicin sulfate. Proc. 8th Iranian Seminar of Pharmaceutical Sciences, Shiraz, I.R. Iran, p131
22- Tafaghodi M., Divan M., Samuel J., Jaafari M.R., Sajadi Tabassi S.A. (2002) Increasing the immune responses by co-delivery of tetanus toxoid and CpG ODN encapsulated in PLGA nanospheres. Proc. 8th Iranian Seminar of Pharmaceutical Sciences, Shiraz, I.R. Iran, p235
23- Tafaghodi M., Sajadi Tabassi S.A., Jaafari M.R. (2002) Preparation and characterization of alginate microspheres encapsulated with tetanus toxoid for nasal delivery. Proc. 8th Iranian Seminar of Pharmaceutical Sciences, Shiraz, I.R. Iran, p236
24- Tafaghodi M., Zakavi S.R., Sajadi Tabassi S.A., Jaafari M.R., Momen-Nejad M. (2002) Gamma-scintigraphy as a novel method to study the distribution and clearance rate of different mucoadhesive nasal delivery systems. Proc. 6th Ann. Meeting Nucl. Med. Iran, Oct 2002, Mashhad. I.R. Iran
25- Tafaghodi, M., Sajadi Tabassi, S.A., Jaafari, M.R.. (2003) Nasal immunization using alginate microspheres encapsulated with tetanus toxoid (TT). Proc. the 1st Congress on Novel Drug Delivery Systems, Tehran, I.R. Iran.
26- Tafaghodi M., Samuel J., Divan M., Sajadi Tabassi S.A., Jaafari M.R. (2003) Utilization of particulate and immunomudulating adjuvants for enhancement of immune response against tumors’ antigenic markers. Proc. 3rd Ir. Conf. Biotech., Mashhad, I.R. Iran
27- Sajadi Tabassi, S.A., Tafaghodi, M., Jaafari, M.R.. (2003) Nasal immunization using cross-linked dextran microspheres encapsulated with tetanus toxoid (TT). Proc. the 1st Congress on Novel Drug Delivery Systems, Tehran, I.R. Iran.
28- Tafaghodi, M., Jaafari, M.R.., Sajadi Tabassi, S.A.( 2003) Nasal immunization using neutral, cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid (TT). Proc. the 1st Congress on Novel Drug Delivery Systems, Tehran, I.R. Iran.
29- Moghimipour E., Ramazani M., Sajadi Tabassi S.A., Loebenberg R. (2003) The enhancing effect of sodium glycocholate and sodium salicylate on the permeability of insulin in rats. Proc. the 1st Congress on Novel Drug Delivery Systems, Tehran, I.R. Iran.
30- Sayyed Abolghassem Sajadi Tabassi, Mohsen Tafaghodi, Mahmoud Reza Jaafari (2005) Evaluation of the effect of some mucoadhesive microspheres on human nasal mucociliary clearance by Gamma-scintigraphy. Proc. 17th Congress of Physiology and Pharmacology of Iran, Kerman.
31- Sajadi Tabassi, S.A., Jaafari, M.R. Shokouhi M. (2004) Preparation and characterization of alginate microspheres loaded with insulin. Proc. 9th Iranian Seminar of Pharmaceutical Sciences, Tabriz, I.R. Iran, p 5
32- Sajadi Tabassi, S. A., Ramezani, M., Jassemi Moghadam, M., (2004) Investigation of Physicochemical Properties and Membrane Effects of the Total Saponins Isolated from Acanthophyllum sordidum. Proc. 3rd Intl. Cong. Health, Environment Nat. Prod., Mashhad. I.R. Iran, p132
33- Sajadi Tabassi, S. A., Ramezani, M., Mashhadi, T., (2005) Extraction and investigation of physicochemical properties and membrane effects of total saponin from Acanthophyllumkorshinskyi. Proc. 1st Seminar of Med. and Nat. Prod. Chem., Shiraz, I.R. Iran, N 96
34- Sajadi Tabassi, S.A., Malaekeh-Nikouei, B., Jaafari, M.R., Davies N. (2006) Preparation and characterization of PLGA microspheres loaded by cyclosporine-cyclodextrin complex. Proc. 10th Iranian Conference of Pharmaceutical Sciences. Tehran, Iran, Aug 2006. Oral Presentation
35- M. Tafaghodi, M. Kharazizadeh,S. A. Sajadi, Preparation and characterization of PLGA nonospheres encapsulated with autoclaved Leishmania major (ALM) and saponin adjuvant. The 3rd Iranain Conference of Novel Drug Delivery Systems, June 2007, Tehran, Iran, O-14.
36- P. Ebrahimnejad, R. Dinarvand, S.A. Sajadi, F. Atyabi, Preparation and Characterization of Betamethasone – Loaded PLGA Nanoparticales. The 3rd Iranain Conference of Novel Drug Delivery Systems, June 2007, Tehran, Iran. P-13.
37- B. Malaekeh-Nikouei , M. R. Jaafari , S. A. Sajadi Tabassi, Preparation, Characterization and Evaluation of Mucoadhesive and Immunosuppressive Properties of Chitosan Coated Liposomes Encapsulated with Cyclosporine A. The 3rd Iranain Conference of Novel Drug Delivery Systems, June 2007, Tehran, Iran. P- 42.
38- S. A. Sajadi Tabassi., Application of Ethics in Pharmacy., The 2nd International Congress of 7Medical Ethics of Iran, April 2008, Tehran University of Medical Sciences, Tehran, Iran, pp 274-276. Oral
39- S. A. Sajadi Tabassi, M. Tafaghodi, M. R. Jaafari, Nasal immunization study by PLGA nanospheres encapsulated with tetanus toxoid and CpG-ODN., 2nd International Congress on Nanoscience and Nanotechnology, October 2008, University of Tabriz, Tabriz, Iran, O-83, Oral
40- P. Ebrahimnejad, F. Atyabi, S.A. Sajadi Tabassi, F. Movaghari, R. Dinarvand; A Novel HPLC Method for Assay of SN-38 in Nanoparticles., 2nd International Congress on Nanoscience and Nanotechnology, October 2008, University of Tabriz, Tabriz, Iran, Poster
41- S. A. Sajadi Tabassi, M. Tafaghodi, M. Kharazizade; PLGA nanospheres loaded by autoclaved Leishmania major (ALM) and Quillaja saponin as adjuvant: a tentative vaccine against Leishmaniasis, 2nd Iran-India Joint Conference on Nanotechnology (IIJCN-2009), University of Isfahan, 5-7 May 2009, Iran, Poster.
42-S. A. Sajadi Tabassi, P. Ebrahimnejad, M. R. Jaafari, F. Atyabi, R. Dinarvand; Encapsulation of SN-38, a novel anticancer drug, in biodegradable nanoparticles: Particle characteristics, in vitro cytotoxicity and evaluation of their body distribution. THE SPECIALIZED CONGRESS AND INTERNATIONAL EXHIBITION OF NANOMEDICINE, NANOBIOTECHNOLOGY, NANOBIOSENSORS AND NANOMATERIALS, 14-16 July 2009, Mashhad, Iran, Oral.
7) كتب تأليف/ ترجمه شده
الف) كتب تأليف شده:
1- Drug Formulary for the Health Centers of Iran: First edition. Ferdowsy University Press, Mashhad, Iran, 1382.
2- Drug Formulary for the Health Centers of Iran: Second edition. Ferdowsy University Press, Mashhad, Iran, 1385.
ب) كتب ترجمه شده:
1) Pharmaceutics: the science of dosage form design. M. Aulton, (ed.), Second edition, Translation to Farsi, Volume 1, Mashhad University of Medical Sciences, 2005.
2) Pharmaceutics: the science of dosage form design. M. Aulton, (ed.), Second edition, Translation to Farsi, Volume 2, Mashhad University of Medical Sciences, 2007.
8) مسئولیت های اجرائی
1) مدیر عامل و عضو هیأت مدیره داروخانه مرکزی امام (1365-1368)
2) مدیر عامل کلینیک ویژه دانشکده داروسازی از سال 1376 تا 1387
3) مدیر داروخانه آموزشی 22 بهمن دانشگاه از سال 1380 تا 1389
4) مدیر گروه فارماسیوتیکس از سال 1379 تا سال 1381 و فروردین 1385 تا خرداد 1387
5) عضو شورای تحصیلا ت تکمیلی دانشکده داروسازی
6) عضو شورای دانشگاه علوم پزشکی مشهد از سال 1385 تا 1386
7) عضو هیئت ممتحنه و ارزشیابی رشته فارماسیوتیکس 3 دوره 2 ساله (ادامه دارد)
8) عضو هیأت تحریریه مجله علوم داروئی ایران (IJPS)
9) عضو شورای پژوهشی دانشکده داروسازی
10) عضو شورای عالی مرکز تحقیقات فارماکولوژی گیاهان داروئی
9) عضویت در سازمان ها
1) عضو سازمان نظام پزشکی ایران
2) عضو انجمن داروسازان ایران
3) عضو انجمن متخصصین علوم داروئی ایران
4- “UK Academy of Pharmaceutical Sciences”, Royal Pharmaceutical Society of Great Britain, London, UK, 1996-present
5- “International Pharmaceutical Federation, FIP, Membership # 24808”, The Netherlands, 2002-present
6- "The International Society of Oncology Pharmacy Practitioners" March 2006-present
10) علایق پژوهشی
1) تهیه و بررسی خصوصیات سیستمهای نوین دارورسانی شامل میکروسفر و نانوسفر حاوی داروهای پیتیدی و غیر پیتیدی
2) بررسی سیستمهای دارورسانی زیست چسب و مخاط چسب
3) مطالعه تاثیر داروها و مواد جانبی بر غشاءهای بیولوژیکی
4) مطالعه جذب پوستی داروها و بررسی تاثیر جذب افزاها
5) بررسی تاثیر ساپونین ها ی استخراج شده از گیاهان بر غشاءها و اثرات جذب افزایی آنها
دانشکده داروسازی
